Login to Your Account

Cydan launches sickle cell-focused Imara with $31M series A

By Michael Fitzhugh
Staff Writer

Thursday, April 14, 2016

Venture-backed orphan drug accelerator Cydan Development Inc. is taking on sickle cell disease (SCD) through the launch of its second new company, Imara Inc.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription